Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors
- PMID: 2463933
Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors
Abstract
Recombinant human interleukin 3 (IL3) produced in Escherichia coli was purified and its activities examined in cultures of highly enriched human bone marrow progenitor cells. Human IL3 stimulated multipotential (CFU-GEMM) and erythroid (BFU-E) progenitor cells, generating 95% more BFU-E than recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF). No further enhancement of BFU-E or CFU-GEMM occurred when IL3 and GM-CSF were used in combination. Human IL3 was more effective than GM-CSF in stimulating granulocyte-macrophage colony-forming cells (CFU-GM) in short-term suspension cultures, but did not induce an increase of CFU-GM, BFU-E, or CFU-GEMM above input levels. IL3 was more active on day-14 (d14) than on d7 CFU-GM, similar to GM-CSF, but generated fewer and smaller CFU-GM-derived clones than either GM-CSF or granulocyte CSF (CI-CSF). The simultaneous addition of plateau levels of IL3 and GM-CSF resulted in an infra-additive augmentation of d7 and d14 CFU-GM-derived clones, whereas IL3 and G-CSF enhanced the number and cellularity predominantly of d14 CFU-GM. In liquid cultures, IL3 induced a greater than 100-fold increase in the number of basophil-mast-like cells and eosinophils and allowed maintenance of these cultures for up to 7 weeks. Human GM-CSF was an almost equally potent, stimulus of eosinophil development but had only a marginal effect on basophilic precursors, whereas G-CSF lacked both activities. Therefore, human IL3 is a multilineage hemopoietic growth factor whose activities appear to encompass and extend beyond those of GM-CSF.
Similar articles
-
Human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates immature marrow precursors but no CFU-GM, CFU-G, or CFU-M.Exp Hematol. 1989 Mar;17(3):292-5. Exp Hematol. 1989. PMID: 2645158
-
Effects of five recombinant hematopoietic growth factors on enriched human erythroid progenitors in serum-replaced cultures.J Cell Physiol. 1989 Mar;138(3):617-23. doi: 10.1002/jcp.1041380324. J Cell Physiol. 1989. PMID: 2647773
-
Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.Stem Cells. 1993 Sep;11(5):435-44. doi: 10.1002/stem.5530110511. Stem Cells. 1993. PMID: 7694721
-
Granulocyte-macrophage colony stimulating factor and interleukin 3: target cells and kinetics of response in vivo.Stem Cells. 1993 Jul;11 Suppl 2:83-7. doi: 10.1002/stem.5530110814. Stem Cells. 1993. PMID: 8401260 Review.
-
Hematopoietic growth factors: biology and clinical application.J Natl Cancer Inst Monogr. 1990;(10):73-7. J Natl Cancer Inst Monogr. 1990. PMID: 1693284 Review.
Cited by
-
Increasing hematopoietic stem cell yield to develop mice with human immune systems.Biomed Res Int. 2013;2013:740892. doi: 10.1155/2013/740892. Epub 2013 Feb 14. Biomed Res Int. 2013. PMID: 23509770 Free PMC article. Review.
-
Preclinical studies and future directions in the development of new hematologic growth factors.Breast Cancer Res Treat. 1991 Dec;20 Suppl:S3-9. doi: 10.1007/BF01908238. Breast Cancer Res Treat. 1991. PMID: 1687205
-
Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study.Br J Cancer. 1997;75(5):703-9. doi: 10.1038/bjc.1997.125. Br J Cancer. 1997. PMID: 9043028 Free PMC article. Clinical Trial.
-
Why clinicians should be interested in interleukin-3.Blut. 1990 Dec;61(6):338-45. doi: 10.1007/BF01738546. Blut. 1990. PMID: 2291980 Review.
-
Effects of interleukin-3 on hematopoietic recovery after 5-fluorouracil or cyclophosphamide treatment of cynomolgus primates.J Clin Invest. 1990 May;85(5):1560-5. doi: 10.1172/JCI114605. J Clin Invest. 1990. PMID: 2332507 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical